In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
CEO disputes have led to speculation the deal could break up, regardless of how the court battle with regulators is decided.
Sangamo Therapeutics, Impax Laboratories and Portola Pharmaceutical are among the premarket movers in biotech.
The drug maker's shares have fallen 6.2% since Wednesday's market open.
The price of EpiPens has surged about 25% annually since 2007.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.